Fingerprint
Dive into the research topics of 'A phase III, randomized, double-blind, placebo-controlled, multinational trial of Iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT Trial)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically